Search results summary
From Health Canada
Search criteria
- Status: Select all
- Company: CELLTRION INC.
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Dormant | 02419483 | CELLTRION INC. | REMSIMA | Human | Yes | Schedule D | 1 | INFLIXIMAB | 100 MG / VIAL |
Dormant | 02419483 | CELLTRION INC. | REMSIMA | Human | Yes | Prescription | 1 | INFLIXIMAB | 100 MG / VIAL |
Approved | 02511576 | CELLTRION INC. | REMSIMA SC | Human | Yes | Schedule D | 1 | INFLIXIMAB | 120 MG / ML |
Approved | 02511576 | CELLTRION INC. | REMSIMA SC | Human | Yes | Prescription | 1 | INFLIXIMAB | 120 MG / ML |
Marketed | 02511584 | CELLTRION INC. | REMSIMA SC | Human | Yes | Prescription | 1 | INFLIXIMAB | 120 MG / ML |
Marketed | 02511584 | CELLTRION INC. | REMSIMA SC | Human | Yes | Schedule D | 1 | INFLIXIMAB | 120 MG / ML |
Marketed | 02534177 | CELLTRION INC. | VEGZELMA | Human | Yes | Schedule D | 1 | BEVACIZUMAB | 100 MG / 4 ML |
Marketed | 02534177 | CELLTRION INC. | VEGZELMA | Human | Yes | Prescription | 1 | BEVACIZUMAB | 100 MG / 4 ML |
Marketed | 02534185 | CELLTRION INC. | VEGZELMA | Human | Yes | Schedule D | 1 | BEVACIZUMAB | 400 MG / 16 ML |
Marketed | 02534185 | CELLTRION INC. | VEGZELMA | Human | Yes | Prescription | 1 | BEVACIZUMAB | 400 MG / 16 ML |
Marketed | 02523760 | CELLTRION INC. | YUFLYMA | Human | Yes | Prescription | 1 | ADALIMUMAB | 40 MG / 0.4 ML |
Marketed | 02523760 | CELLTRION INC. | YUFLYMA | Human | Yes | Schedule D | 1 | ADALIMUMAB | 40 MG / 0.4 ML |
Marketed | 02523779 | CELLTRION INC. | YUFLYMA | Human | Yes | Prescription | 1 | ADALIMUMAB | 40 MG / 0.4 ML |
Marketed | 02523779 | CELLTRION INC. | YUFLYMA | Human | Yes | Schedule D | 1 | ADALIMUMAB | 40 MG / 0.4 ML |
Marketed | 02535076 | CELLTRION INC. | YUFLYMA | Human | Yes | Schedule D | 1 | ADALIMUMAB | 80 MG / 0.8 ML |
Marketed | 02535076 | CELLTRION INC. | YUFLYMA | Human | Yes | Prescription | 1 | ADALIMUMAB | 80 MG / 0.8 ML |
Marketed | 02535084 | CELLTRION INC. | YUFLYMA | Human | Yes | Prescription | 1 | ADALIMUMAB | 80 MG / 0.8 ML |
Marketed | 02535084 | CELLTRION INC. | YUFLYMA | Human | Yes | Schedule D | 1 | ADALIMUMAB | 80 MG / 0.8 ML |
Application information
Related information
Contact us
Version 4.0.2